Colorful pills and brain

(Credit: izzuanroslan/Shutterstock)

SOLNA, Sweden — Several of the drugs that patients take to protect their cardiovascular health may also provide a hidden benefit. Researchers in Sweden have found that long-term use of drugs for hypertension and high cholesterol also lowers the risk of developing dementia.

The research, conducted using Swedish national health registries, suggests that certain heart drugs play a crucial role in protecting brain health. These include diuretics, blood pressure medications, cholesterol-lowering drugs, and blood thinners.

Scientists from the Karolinska Institutet discovered that people who consistently took these specific heart medications for over five years had significantly lower chances of developing dementia. Not all drugs were created equal, however. While some medications showed protective effects, others surprisingly increased dementia risk.

“Previous studies have focused on individual drugs and specific patient groups but in this study, we take a broader approach,” notes lead author Alexandra Wennberg, an affiliated researcher at the Institute of Environmental Medicine, in a university release.

The study, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, examined data from a staggering 88,065 dementia patients and 880,650 healthy control participants, all over the age of 70. This massive dataset allowed researchers to track medication use and dementia diagnoses with unprecedented detail.

Diuretics, drugs for hypertension, medications for high cholesterol, and blood thinners all emerged as potential brain defenders. Patients using these medications for five to 10 years showed approximately 25% lower odds of developing dementia compared to non-users. Interestingly, combining multiple drugs within these classes seemed to enhance the protective effect. Simply put, using more than one of these drugs boosted their brain-protecting effects.

“We currently have no cure for dementia, so it’s important to find preventive measures,” Wennberg adds.

Heart and brain connection
People who consistently took these specific heart medications for over five years had significantly lower chances of developing dementia. (© TanyaJoy – stock.adobe.com)

Not all heart medications were beneficial

Antiplatelet drugs, commonly prescribed to prevent blood clots, displayed a connection to a higher risk of dementia. This finding is particularly significant given how frequently these medications are prescribed.

Researchers propose several reasons why these drugs might help protect brain health. They could potentially reduce inflammation, improve blood vessel health, protect against cerebrovascular injury, and potentially lower harmful protein accumulation in the brain.

While the study doesn’t prove these drugs definitively prevent dementia, it provides compelling evidence that long-term cardiovascular treatment could have unexpected brain benefits. The researchers meticulously analyzed Swedish national health registries, tracking medication use and dementia diagnoses over several years. They carefully controlled for factors like age, sex, education, and existing health conditions to ensure the reliability of their findings.

The researchers note that more studies are necessary to prove a definitive connection. This current research shows an association, not direct causation. However, the study underscores the complex connections between cardiovascular and brain health, offering a glimmer of hope in the ongoing fight against dementia.

Paper Summary

Methodology

To understand how the researchers conducted this groundbreaking study, they used comprehensive national health registries in Sweden, which track detailed medical information for millions of people. By linking different databases, they could follow individuals’ medication use and track subsequent dementia diagnoses.

The researchers selected 88,065 people diagnosed with dementia after age 70, between 2011 and 2016. For each dementia patient, they identified ten matched control subjects without dementia. This allowed them to compare medication use between those who developed dementia and those who did not.

Key Results

The study revealed nuanced findings about cardiovascular medications and dementia risk. Long-term users (five years or more) of diuretics, blood pressure medications, cholesterol-lowering drugs, and blood thinners showed lower dementia rates. Specifically, using these medications for 5-10 years reduced dementia risk by approximately 25%.

Interestingly, short-term medication use (1-4 years) was actually associated with slightly higher dementia risk. The researchers suggest this could be because individuals starting medications might already have underlying health conditions affecting brain health.

Study Limitations

The researchers could not definitively prove these drugs prevent dementia, only that they’re associated with lower risk. They also acknowledged potential missed diagnoses and the challenges of using registry data.

Discussion & Takeaways

The research suggests that long-term cardiovascular treatment might have unexpected neurological benefits. The protective effect seemed most pronounced when patients used multiple complementary medications. However, the study also raised a red flag about antiplatelet drugs, which were associated with higher dementia risk.

Funding & Disclosures

The study was funded by research foundations at Karolinska Institutet. The researchers declared no significant conflicts of interest, and funding sources were not involved in the study design or analysis.

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment